This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: Indications for assessment of patient's response to bronchodilator therapy include which of the ... (Read 26 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
on: Jul 16, 2018
Indications for assessment of patient's response to bronchodilator therapy include which of the following?
 
  a. Confirm whether the therapy works as intended.
  b. Individualize the dose, frequency, or type of medication.
  c. Help follow the patient's status during long-term therapy.
  d. Quantify the degree of bronchial hyperresponsiveness .
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 3 and 4 only
  d. 2, 3, and 4 only

Question 2

Appropriate documentation when conducting point-of-care assessment of a patient's response to bronchodilator therapy includes which of the following?
 
  a. Medication type, dose, and time received
  b. Vital signs, breath sounds, and pulmonary function test measures
  c. Patient's progress and ability to self-assess symptoms
  d. Blood levels of the bronchodilator agent
  a. 1 and 2 only
  b. 1, 2, and 3 only
  c. 3 and 4 only
  d. 1, 2, 3, and 4


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Briannahope

  • Sr. Member
  • ****
  • Posts: 364
Reply #1 on: Jul 16, 2018
Answer to Question 1

ANS: B
The AARC has published Clinical Practice Guideline: Assessing Response to Bronchodilator Therapy at Point of Care. See Box 39-8.

Answer to Question 2

ANS: B
The AARC has published Clinical Practice Guideline: Assessing Response to Bronchodilator Therapy at Point of Care. See Box 39-8.


captainjonesify

  • Member
  • Posts: 543
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it

sarah_brady415

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

« previous next »
 

Did you know?

Every flu season is different, and even healthy people can get extremely sick from the flu, as well as spread it to others. The flu season can begin as early as October and last as late as May. Every person over six months of age should get an annual flu vaccine. The vaccine cannot cause you to get influenza, but in some seasons, may not be completely able to prevent you from acquiring influenza due to changes in causative viruses. The viruses in the flu shot are killed—there is no way they can give you the flu. Minor side effects include soreness, redness, or swelling where the shot was given. It is possible to develop a slight fever, and body aches, but these are simply signs that the body is responding to the vaccine and making itself ready to fight off the influenza virus should you come in contact with it.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Urinary catheterization. The procedure involves the insertion of a flexible tube, or catheter, throu Urinary catheterization. The procedure involves the insertion of a flexible tube, or catheter, throu
Teaching an illterate patient Teaching an illterate patient
Nursing history for male genetalia assessment Nursing history for male genetalia assessment
Flow data for a healthy donor (top panel) and a HIV positive patient. CD3 is a T-cell marker, CD4 is ... Flow data for a healthy donor (top panel) and a HIV positive patient. CD3 is a T-cell marker, CD4 is ...
Head of a patient with tertiary syphilis. Head of a patient with tertiary syphilis.
Ex vivo and in vivo gene therapy for a patient with a liver disorder Ex vivo and in vivo gene therapy for a patient with a liver disorder
Video: How proteins function? How do proteins work?

For a complete list of videos, visit our video library